Persistence of Second and Third-Line Biologics in Inflammatory Bowel Disease: A Multi-Centre Cohort Study

• Główni autorzy: Timothy P. Hanrahan (Autor), Robbie Chan (Autor), Daniel Tassone (Autor), Nik S. Ding (Autor), Chamara Basnayake (Autor), Julien Schulberg (Autor), Abhinav Vasudevan (Autor), Michael Kamm (Autor), Michael De Gregorio (Autor), Daniel R. van Langenberg (Autor), Ola Niewiadomski (Autor)
• Format: Książka
• Wydane: MDPI AG, 2022-12-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Background: Despite proven efficacy of biologics in inflammatory bowel disease (IBD), many exhibit primary non-response or secondary loss of response and switch to subsequent biologic(s). Here, we identified early predictors of second- and/or third-line biologic persistence in IBD, in a real-world c...